Technical Analysis for ATAI - ATAI Life Sciences N.V.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
D | 1.67 | -5.65% | -0.10 |
ATAI closed down 5.65 percent on Monday, March 18, 2024, on approximately normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
Earnings due: Mar 19
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
MACD Bearish Centerline Cross | Bearish | 0.00% | |
Lower Bollinger Band Touch | Weakness | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
Calm After Storm | Range Contraction | -5.65% | |
NR7 | Range Contraction | -5.65% | |
Inside Day | Range Contraction | -5.65% | |
Oversold Stochastic | Weakness | -5.65% | |
50 DMA Resistance | Bearish | -0.60% | |
New Downtrend | Bearish | -0.60% | |
Stochastic Reached Oversold | Weakness | -0.60% |
Alert | Time |
---|---|
3x Volume Pace | about 18 hours ago |
2x Volume Pace | about 18 hours ago |
1.5x Volume Pace | about 18 hours ago |
Down 5% | about 18 hours ago |
Down 3% | about 18 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 03/19/2024
atai is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai was founded in 2018 as a response to the significant unmet need and lack of innovation in the mental health treatment landscape, as well as the emergence of therapies that previously may have been overlooked or underused, including psychedelic compounds and digital therapeutics. atai is headquartered in Berlin, with offices in New York and London.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Medication Disability Mental Health Psychiatry Mental Disorder Mental Health Disorders Positive Psychology
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Medication Disability Mental Health Psychiatry Mental Disorder Mental Health Disorders Positive Psychology
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 2.39 |
52 Week Low | 1.025 |
Average Volume | 1,492,092 |
200-Day Moving Average | 1.60 |
50-Day Moving Average | 1.87 |
20-Day Moving Average | 1.94 |
10-Day Moving Average | 1.92 |
Average True Range | 0.17 |
RSI (14) | 41.18 |
ADX | 30.42 |
+DI | 18.07 |
-DI | 26.04 |
Chandelier Exit (Long, 3 ATRs) | 1.81 |
Chandelier Exit (Short, 3 ATRs) | 2.11 |
Upper Bollinger Bands | 2.21 |
Lower Bollinger Band | 1.66 |
Percent B (%b) | 0.01 |
BandWidth | 28.42 |
MACD Line | -0.01 |
MACD Signal Line | 0.04 |
MACD Histogram | -0.0485 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 1.94 | ||||
Resistance 3 (R3) | 1.95 | 1.87 | 1.90 | ||
Resistance 2 (R2) | 1.87 | 1.80 | 1.87 | 1.88 | |
Resistance 1 (R1) | 1.77 | 1.76 | 1.73 | 1.76 | 1.86 |
Pivot Point | 1.69 | 1.69 | 1.67 | 1.69 | 1.69 |
Support 1 (S1) | 1.59 | 1.62 | 1.55 | 1.58 | 1.48 |
Support 2 (S2) | 1.51 | 1.58 | 1.51 | 1.46 | |
Support 3 (S3) | 1.41 | 1.51 | 1.45 | ||
Support 4 (S4) | 1.40 |